State Street®HlthCrSelSectSPDR®ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
State Street® Health Care Select Sector SPDR® ETF XLV
Morningstar’s Analysis XLV
Will XLV outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 60.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 15.47 | 7B | Healthcare |
Johnson & Johnson | 10.13 | 4B | Healthcare |
AbbVie Inc | 7.80 | 3B | Healthcare |
Merck & Co Inc | 5.73 | 2B | Healthcare |
UnitedHealth Group Inc | 5.49 | 2B | Healthcare |
Thermo Fisher Scientific Inc | 3.98 | 2B | Healthcare |
Amgen Inc | 3.63 | 2B | Healthcare |
Gilead Sciences Inc | 2.96 | 1B | Healthcare |
Abbott Laboratories | 2.78 | 1B | Healthcare |
Pfizer Inc | 2.59 | 1B | Healthcare |